#oncology — Thursday, August 06, 2026 (1 items)
| 0 | 💬 0 |
Intracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-08-06 | #immunotherapy #car-t #glioblastoma #clinical trial #oncology |